Remove Disease Remove Pharma R&D Remove Research
article thumbnail

Quantum Computing: Boehringer Ingelheim and Google Partner for Pharma R&D

The Pharma Data

.–( BUSINESS WIRE )– Boehringer Ingelheim announced today a collaborative agreement with Google Quantum AI (Google), focusing on researching and implementing cutting-edge use cases for quantum computing in pharmaceutical research and development (R&D), specifically including molecular dynamics simulations.

article thumbnail

Rethinking the pharma R&D lifecycle with AI in mind

Drug Discovery World

Within the next five to 10 years, AI will fundamentally change the way drugs are designed, with the potential to produce an order of magnitude for more high-quality candidates against a broad range of new diseases. It had a tremendous impact, leading to breakthroughs for debilitating diseases like cystic fibrosis.